Document Detail


Long term treatment of myasthenia gravis with azathioprine.
MedLine Citation:
PMID:  2112245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunction with pyridostigmine and prednisolone for a total of 138 patient years. Side effects necessitated discontinuation of treatment in only four patients. Treatment with azathioprine was associated with marked clinical improvement in all the remaining 23 patients, resulting in reduction in the dose of pyridostigmine and prednisolone. The number of hospital admissions as well as the number of episodes of respiratory failure were markedly reduced.
Authors:
V Fonseca; C W Havard
Related Documents :
11707845 - Biological correlates of acute hypersensitivity events with dab(389)il-2 (denileukin di...
8183775 - Splenectomy in patients with undiagnosed splenomegaly.
17130775 - Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quan...
21898075 - Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to syn...
24741515 - Circulating adiponectin levels in indian patients with psoriasis and its relation to me...
8453805 - Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Postgraduate medical journal     Volume:  66     ISSN:  0032-5473     ISO Abbreviation:  Postgrad Med J     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-07-09     Completed Date:  1990-07-09     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0234135     Medline TA:  Postgrad Med J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  102-5     Citation Subset:  IM    
Affiliation:
Royal Free Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Azathioprine / adverse effects,  therapeutic use*
Drug Therapy, Combination
Female
Humans
Hypertension, Portal / chemically induced
Jaundice / chemically induced
Long-Term Care
Male
Middle Aged
Myasthenia Gravis / drug therapy*
Prednisolone / therapeutic use
Pyridostigmine Bromide / therapeutic use
Chemical
Reg. No./Substance:
101-26-8/Pyridostigmine Bromide; 446-86-6/Azathioprine; 50-24-8/Prednisolone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of thr...
Next Document:  Dynamics of accumulation of extracellular lipoteichoic acid in Bacillus cereus